NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU

Clinical trials for NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU explained in plain language.

Never miss a new study

Get alerted when new NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU trials appear

Sign up with your email to follow new studies for NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet recruiting 1

New bladder cancer drug trial offers hope for patients who Can't get standard treatment

Disease control Not yet recruiting

This study is testing whether a new treatment called TARA-002 works better than standard chemotherapy for adults with high-grade non-muscle invasive bladder cancer who haven't received BCG therapy. Researchers will give TARA-002 directly into the bladder and compare it to standar…

Matched conditions: NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU

Phase: PHASE3 • Sponsor: Protara Therapeutics • Aim: Disease control

Last updated Apr 01, 2026 14:41 UTC

NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU

Get alerted when new NON-MUSCLE INVASIVE BLADDER CANCER WITH CARCINOMA IN SITU trials appear

New bladder cancer drug trial offers hope for patients who Can't get standard treatment